{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:11:52Z","timestamp":1791357112588,"version":"4.3.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T00:00:00Z","timestamp":1350950400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-244x-12-177","type":"journal-article","created":{"date-parts":[[2012,10,23]],"date-time":"2012-10-23T06:18:41Z","timestamp":1350973121000},"source":"Crossref","is-referenced-by-count":17,"title":["Change in healthcare utilization and costs following initiation of benzodiazepine therapy for long-term treatment of generalized anxiety disorder: a retrospective cohort study"],"prefix":"10.1186","volume":"12","author":[{"given":"Ariel","family":"Berger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Edelsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Treglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ma J","family":"Alvir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Oster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,23]]},"reference":[{"key":"1067_CR1","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 2000, Text Revision. American Psychiatric Association, Washington, DC, 4","edition":"4"},{"key":"1067_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1192\/bjp.176.6.544","volume":"176","author":"KA Yonkers","year":"2000","unstructured":"Yonkers KA, Dyck IR, Warshaw M, Keller MB: Factors predicting the clinical course of generalised anxiety disorder. Br J Psychiatry. 2000, 176: 544-549. 10.1192\/bjp.176.6.544.","journal-title":"Br J Psychiatry"},{"key":"1067_CR3","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","volume":"62","author":"R Kessler","year":"2005","unstructured":"Kessler R, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE: Lifetime prevalence and age of onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005, 62: 593-602. 10.1001\/archpsyc.62.6.593.","journal-title":"Arch Gen Psychiatry"},{"key":"1067_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.euroneuro.2005.04.010","volume":"15","author":"R Lieb","year":"2005","unstructured":"Lieb R, Becker E, Altamura C: The epidemiology of generalized anxiety disorder in Europe. Eur Neuropsychopharmacol. 2005, 15: 445-452. 10.1016\/j.euroneuro.2005.04.010.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1067_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/00004850-200015060-00002","volume":"15","author":"HU Wittchen","year":"2000","unstructured":"Wittchen HU, Carter RM, Pfister H, Montgomery SA, Kessler RC: Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int Clin Psychopharmacol. 2000, 15: 319-328. 10.1097\/00004850-200015060-00002.","journal-title":"Int Clin Psychopharmacol"},{"key":"1067_CR6","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1001\/jama.1994.03520220035028","volume":"272","author":"J Ormel","year":"1994","unstructured":"Ormel J, VonKorff M, Ustun TB, Pini S, Korten A, Oldehinkel T: Common mental disorders and disability across cultures: Results from the WHO collaborative study on psychological problems in general health care. JAMA. 1994, 272: 1741-1748. 10.1001\/jama.1994.03520220035028.","journal-title":"JAMA"},{"key":"1067_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/da.10065","volume":"16","author":"HU Wittchen","year":"2002","unstructured":"Wittchen HU: Generalized anxiety disorder: Prevalence, burden, and cost to society. Depress Anxiety. 2002, 16: 162-171. 10.1002\/da.10065.","journal-title":"Depress Anxiety"},{"key":"1067_CR8","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1176\/ps.2006.57.12.1738","volume":"57","author":"P Munk-Jorgensen","year":"2006","unstructured":"Munk-Jorgensen P, Allgulander C, Dahl AA, Foldager L, Holm M, Rasmussen I, Virta A, Huuhtanen MT, Wittchen HU: Prevalence of generalized anxiety disorder in general practice in Denmark, Finland, Norway, and Sweden. Psychiatr Serv. 2006, 57: 1738-1744. 10.1176\/appi.ps.57.12.1738.","journal-title":"Psychiatr Serv"},{"key":"1067_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1017\/S1461145704004870","volume":"8","author":"DS Baldwin","year":"2005","unstructured":"Baldwin DS, Polkinghorn C: Evidence-based pharmacotherapy of generalized anxiety disorder. Int J Neuropsychopharmacol. 2005, 8: 293-302. 10.1017\/S1461145704004870.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1067_CR10","volume-title":"NICE guideline, draft for consultation, July 2010. World Wide Web","author":"National Institute for Health and Clinical Excellence (NICE)","year":"2010","unstructured":"National Institute for Health and Clinical Excellence (NICE): Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults: Management in primary, secondary and community care (partial update). NICE guideline, draft for consultation, July 2010. World Wide Web. 2010, http:\/\/www.nice.org.uk\/nicemedia\/live\/12147\/49816\/49816.pdf . Accessed August 25, 2011"},{"key":"1067_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/15622970802465807","volume":"9","author":"B Bandelow","year":"2008","unstructured":"Bandelow B, Zohar J, Hollander E, Kasper S, Moller HJ: World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders\u2014first revision. World J Biol Psychiatry. 2008, 9: 248-312. 10.1080\/15622970802465807.","journal-title":"World J Biol Psychiatry"},{"key":"1067_CR12","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2165\/00023210-200317110-00004","volume":"17","author":"RG Cumming","year":"2003","unstructured":"Cumming RG, LeCouteur DG: Benzodiazepines and risk of hip fractures in older people: A review of the evidence. CNS Drugs. 2003, 17: 825-837. 10.2165\/00023210-200317110-00004.","journal-title":"CNS Drugs"},{"key":"1067_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1179\/acb.2003.58.1.004","volume":"58","author":"M Petrovic","year":"2003","unstructured":"Petrovic M, Mariman A, Warie H, Afschrift M, Pevernagie D: Is there a rationale for prescription of benzodiazepines in the elderly? Review of the literature. Acta Clin Belg. 2003, 58: 27-36.","journal-title":"Acta Clin Belg"},{"key":"1067_CR14","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2165\/00002018-199921020-00004","volume":"21","author":"SL Gray","year":"1999","unstructured":"Gray SL, Lai KV, Larson EB: Drug-induced cognition disorders in the elderly: Incidence, prevention and management. Drug Saf. 1999, 21: 101-122. 10.2165\/00002018-199921020-00004.","journal-title":"Drug Saf"},{"key":"1067_CR15","first-page":"799","volume":"44","author":"RE Thomas","year":"1998","unstructured":"Thomas RE: Benzodiazepine use and motor vehicle accidents. Systematic review of reported associated. Can Fam Physician. 1998, 44: 799-808.","journal-title":"Can Fam Physician"},{"key":"1067_CR16","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1056\/NEJM199305133281907","volume":"328","author":"RI Shader","year":"1993","unstructured":"Shader RI, Greenblatt DJ: Use of benzodiazepines in anxiety disorders. N Engl J Med. 1993, 328: 1398-1405. 10.1056\/NEJM199305133281907.","journal-title":"N Engl J Med"},{"key":"1067_CR17","first-page":"24","volume":"64","author":"JM Gorman","year":"2003","unstructured":"Gorman JM: Treating generalized anxiety disorder. J Clin Psychiatry. 2003, 64: 24-29.","journal-title":"J Clin Psychiatry"},{"key":"1067_CR18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1017\/S1092852900006945","volume":"8","author":"C Allgulander","year":"2003","unstructured":"Allgulander C, Bandelow B, Hollander E, Montgomery SA, Nutt DJ, Okasha A, Pollack MH, Stein DJ, Swinson RP: WCA recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectr. 2003, 8: 53-61.","journal-title":"CNS Spectr"},{"key":"1067_CR19","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1185\/030079905X48401","volume":"21","author":"ME Kaplan","year":"2005","unstructured":"Kaplan ME, DuPont RL: Benzodiazepines and anxiety disorders: A review for the practicing physician. Curr Med Res Opin. 2005, 21: 941-950. 10.1185\/030079905X48401.","journal-title":"Curr Med Res Opin"},{"key":"1067_CR20","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1586\/14737175.8.8.1189","volume":"8","author":"M Lader","year":"2008","unstructured":"Lader M: Effectiveness of benzodiazepines: Do they work or not?. Expert Rev Neurother. 2008, 8: 1189-1191. 10.1586\/14737175.8.8.1189.","journal-title":"Expert Rev Neurother"},{"key":"1067_CR21","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1001\/archinte.1991.00400090107019","volume":"151","author":"MH Beers","year":"1991","unstructured":"Beers MH, Ouslander JG, Rollinger I, Reuben DB, Brooks J, Beck JC: Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991, 151: 1825-1832. 10.1001\/archinte.1991.00400090107019.","journal-title":"Arch Intern Med"},{"key":"1067_CR22","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1001\/archinte.1997.00440350031003","volume":"157","author":"MH Beers","year":"1997","unstructured":"Beers MH: Explicit criteria for determining potentially inappropriate medication use by the elderly: An update. Arch Intern Med. 1997, 157: 1531-1536. 10.1001\/archinte.1997.00440350031003.","journal-title":"Arch Intern Med"},{"key":"1067_CR23","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1001\/jama.286.22.2823","volume":"286","author":"C Zhan","year":"2001","unstructured":"Zhan C, Sangl J, Bierman AS, Miller MR, Friedman B, Wickizer SW, Meyer GS: Potentially inappropriate medication use in the community-dwelling elderly: Findings from the 1996 Medical Expenditure Panel Survey. JAMA. 2001, 286: 2823-2829. 10.1001\/jama.286.22.2823.","journal-title":"JAMA"},{"key":"1067_CR24","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.2105\/AJPH.80.12.1467","volume":"90","author":"G Oster","year":"1990","unstructured":"Oster G, Huse DM, Adams SF, Imbimbo J, Russell MW: Benzodiazepine tranquilizers and the risk of accidental injury. Am J Public Health. 1990, 90: 1467-1470.","journal-title":"Am J Public Health"},{"key":"1067_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1532-5415.2005.53108.x","volume":"53","author":"R Tamblyn","year":"2005","unstructured":"Tamblyn R, Abrahamowicz M, Du Berger R, McLeod P, Bartlett G: A 5-year prospective assessment of the risk associated with individual benzodiazepines and doses in new elderly users. J Am Geriatr Soc. 2005, 53: 233-241. 10.1111\/j.1532-5415.2005.53108.x.","journal-title":"J Am Geriatr Soc"},{"key":"1067_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1365-2710.1992.tb01281.x","volume":"17","author":"VF Trewin","year":"1992","unstructured":"Trewin VF, Lawrence CJ, Veitch GB: An investigation of the association of benzodiazepines and other hypnotics with the incidence of falls in the elderly. J Clin Pharm Ther. 1992, 17: 129-133.","journal-title":"J Clin Pharm Ther"},{"key":"1067_CR27","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00198-005-0065-y","volume":"17","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L: Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fractures. Osteoporos Int. 2006, 17: 807-816. 10.1007\/s00198-005-0065-y.","journal-title":"Osteoporos Int"},{"key":"1067_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0741-8329(02)00223-9","volume":"28","author":"M Stenbacka","year":"2002","unstructured":"Stenbacka M, Jannson B, Leifman A, Romelsjo A: Associated between use of sedatives or hypnotics, alcohol consumption, or other risk factors and a single injurious fall or multiple injurious falls: A longitudinal general population study. Alcohol. 2002, 28: 9-16. 10.1016\/S0741-8329(02)00223-9.","journal-title":"Alcohol"},{"key":"1067_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2165\/00002512-200825010-00007","volume":"25","author":"A Pariente","year":"2008","unstructured":"Pariente A, Dartigues JF, Benichou J, Letenneur L, Moore N, Fourrier-Reglat A: Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging. 2008, 25: 61-70. 10.2165\/00002512-200825010-00007.","journal-title":"Drugs Aging"},{"key":"1067_CR30","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0140-6736(98)04087-2","volume":"352","author":"F Barbone","year":"1998","unstructured":"Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, MacDonald TM: Association of road-traffic accidents with benzodiazepine use. Lancet. 1998, 352: 1331-1336. 10.1016\/S0140-6736(98)04087-2.","journal-title":"Lancet"},{"key":"1067_CR31","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/JGP.0b013e31817c6a99","volume":"16","author":"CM Chang","year":"2008","unstructured":"Chang CM, We UC, Chang IS, Lin KM: Benzodiazepine and risk of hip fractures in older people: A nested case\u2013control study in Taiwan. Am J Geriatr Psych. 2008, 16: 686-692. 10.1097\/JGP.0b013e31817c6a99.","journal-title":"Am J Geriatr Psych"},{"key":"1067_CR32","doi-asserted-by":"publisher","first-page":"663","DOI":"10.4088\/JCP.08m04325","volume":"70","author":"MJ Rapoport","year":"2009","unstructured":"Rapoport MJ, Lanctot KL, Streiner DL, Bedard M, Vingilis E, Murray B, Schaffer A, Shulman KI, Herrmann N: Benzodiazepine use and driving: A meta-analysis. J Clin Psychiatry. 2009, 70: 663-673. 10.4088\/JCP.08m04325.","journal-title":"J Clin Psychiatry"},{"key":"1067_CR33","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1017\/S1355617705050332","volume":"11","author":"MJ Barker","year":"2005","unstructured":"Barker MJ, Greenwood KM, Jackson M, Crowe SF: An evaluation of persisting cognitive effects after withdrawal from long-term benzodiazepine use. J Int Neuropsychol Soc. 2005, 11: 281-289.","journal-title":"J Int Neuropsychol Soc"},{"key":"1067_CR34","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.2165\/00002512-200724120-00007","volume":"24","author":"J Puustinen","year":"2007","unstructured":"Puustinen J, Nurminen J, Kukola M, Vahlberg T, Laine K, Kivela SL: Associations between use of benzodiazepines or related drugs and health, physical abilities and cognitive function: A non-randomised clinical study in the elderly. Drugs Aging. 2007, 24: 1045-1059. 10.2165\/00002512-200724120-00007.","journal-title":"Drugs Aging"},{"key":"1067_CR35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/CCM.0b013e318192fcf9","volume":"37","author":"MA Pisani","year":"2009","unstructured":"Pisani MA, Murphy TE, Araujo KL, Slattum P, Van Ness PH, Inouye SK: Benzodiazepine and opioid use and the duration of intensive care unit delirium in an older population. Crit Care Med. 2009, 37: 177-183. 10.1097\/CCM.0b013e318192fcf9.","journal-title":"Crit Care Med"},{"key":"1067_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1532-5415.1998.tb01016.x","volume":"46","author":"LD Ried","year":"1998","unstructured":"Ried LD, Johnson RE, Gettman DA: Benzodiazepine exposure and functional status in older people. J Am Geriatr Soc. 1998, 46: 71-76.","journal-title":"J Am Geriatr Soc"},{"key":"1067_CR37","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S0009-9236(98)90059-5","volume":"64","author":"JT Hanlon","year":"1998","unstructured":"Hanlon JT, Horner RD, Schmader KE, Fillenbaum GG, Lewis IK, Wall WE, Landerman LR, Pieper CF, Blazer DG, Cohen HJ: Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther. 1998, 64: 684-692. 10.1016\/S0009-9236(98)90059-5.","journal-title":"Clin Pharmacol Ther"},{"key":"1067_CR38","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0895-4356(01)00453-X","volume":"55","author":"R Lagnaoui","year":"2002","unstructured":"Lagnaoui R, Begaud B, Moore N, Chaslerie A, Fourrier A, Letenneur L, Dartigues JF, Moride Y: Benzodiazepine use and risk of dementia: A nested case\u2013control study. J Clin Epidemiol. 2002, 55: 314-318. 10.1016\/S0895-4356(01)00453-X.","journal-title":"J Clin Epidemiol"},{"key":"1067_CR39","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1017\/S1461145710001434","volume":"14","author":"DS Baldwin","year":"2011","unstructured":"Baldwin DS, Waldman S, Allgulander C: Evidence-based pharmacological treatment of generalized anxiety disorder. Int J Neuropsychopharmacol. 2011, 14: 697-710. 10.1017\/S1461145710001434.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1067_CR40","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1177\/0269881105059253","volume":"196","author":"DS Baldwin","year":"2005","unstructured":"Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JRT, den Boer JA, Fineberg NA, Knapp M, Scott J, Wittchen HU: Evidence-based guidelines for the pharmacological treatment of anxiety disorders: Recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2005, 196: 567-596.","journal-title":"J Psychopharmacol"},{"key":"1067_CR41","first-page":"53","volume":"62","author":"JC Ballenger","year":"2001","unstructured":"Ballenger JC, Davidson JRT, Lecrubier Y, Nutt DJ, Borkovec TD, Rickels K, Stein DJ, Wittchen HU: Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry. 2001, 62: 53-58.","journal-title":"J Clin Psychiatry"},{"key":"1067_CR42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/1471-244X-11-193","volume":"11","author":"A Berger","year":"2011","unstructured":"Berger A, Edelsberg J, Bollu V, Alvir JMJ, Dugar A, Joshi AV, Oster G: Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: A retrospective cohort study. BMC Psychiatry. 2011, 11: 193-10.1186\/1471-244X-11-193.","journal-title":"BMC Psychiatry"},{"key":"1067_CR43","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/j.ehrm.2011.11.002","volume":"3","author":"A Berger","year":"2012","unstructured":"Berger A, Edelsberg J, Bollu V, Alvir JMJ, Dugar A, Joshi AV, Oster G: Healthcare utilization and costs in patients with generalized anxiety disorder initiating add-on therapy with benzodiazepines. Health Outcomes Res Med. 2012, 3: e45-e54. 10.1016\/j.ehrm.2011.11.002.","journal-title":"Health Outcomes Res Med"},{"key":"1067_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1600-0447.2000.tb10947.x","volume":"101","author":"J Zohar","year":"2000","unstructured":"Zohar J, Westenberg HG: Anxiety disorders: A review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatrica Scan. 2000, 101: 39-49. 10.1111\/j.1600-0447.2000.tb10947.x.","journal-title":"Acta Psychiatrica Scan"},{"key":"1067_CR45","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/msj.20041","volume":"75","author":"EJ Hoffman","year":"2008","unstructured":"Hoffman EJ, Mattew SJ: Anxiety disorders: A comprehensive review of pharmacotherapies. Mt Sinai J Med. 2008, 75: 248-262. 10.1002\/msj.20041.","journal-title":"Mt Sinai J Med"},{"key":"1067_CR46","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1017\/S1092852900009901","volume":"10","author":"DJ Nutt","year":"2005","unstructured":"Nutt DJ: Overview of diagnosis and drug treatments of anxiety disorders. CNS Spectr. 2005, 10: 49-56.","journal-title":"CNS Spectr"},{"key":"1067_CR47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/da.20089","volume":"22","author":"RG Vasile","year":"2005","unstructured":"Vasile RG, Bruce SE, Goisman RM, Pagano M, Keller MB: Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobia. Depress Anxiety. 2005, 22: 59-67. 10.1002\/da.20089.","journal-title":"Depress Anxiety"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-12-177\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-12-177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T01:44:47Z","timestamp":1498009487000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-12-177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,23]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1067"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-12-177","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,23]]},"article-number":"177"}}